Fotona’s Gynecology Solutions Gain Recognition in Recently Published Scientific Articles
28 January 2022
Fotona is pleased to announce that its minimally invasive gynecology applications have been featured in three recently published articles appearing in highly respected peer-reviewed journals:
- Drs. Gambacciani & Fidecicchi have shown that 3 treatment sessions with SMOOTH™ mode can rapidly and significantly improve symptoms of superficial dyspareunia in sexually active postmenopausal women. The addition of Nd:YAG PIANO mode to the treatment protocol results in even more dramatic improvement of symptoms.
Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study. Gambacciani M & Fidecicchi T, Climacteric. Read full article online.
- The latest paper from Dr. Gaspar confirms previous findings that the IncontiLase® procedure is a valid and reliable treatment option for patients with stress urinary incontinence (SUI). With its longitudinal design it proposes a novel treatment regimen with maintenance treatments for a sustained effect and confirms that repeated treatments with the non-ablative Er:YAG laser is safe.
Vaginal erbium laser for treatment of stress urinary incontinence: optimization of treatment regimen for a sustained long-term effect. Gaspar A, et al. Lasers in Medical Science. Read full article online.
- The results of a study conducted by Dr. Lin show that non-ablative Er:YAG laser treatment is an effective way to improve bothersome problems related to GSM for at least 1 year, which further supports findings made by other researchers who are using RenovaLase® for treatment of GSM.
The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM). Lin K, et al. Lasers in Medical Science. Read full article online.
Fotona’s innovative SMOOTH™ applications in gynecology such as IntimaLase®, IncontiLase®, RenovaLase® and ProlapLase® have received exceptionally high interest at worldwide industry events along with substantial praise from the scientific community. We believe these latest published articles further recognize and confirm the significance of Fotona's pioneering research efforts in the field of minimally invasive gynecology, and we are very excited to see that increasing numbers of practitioners now consider laser treatment to be one of the best options for treating disorders such as SUI, GSM and superficial dyspareunia.
For more information please visit the Fotona SMOOTH® website which is tailored for both patients and doctors.